000156568 001__ 156568 000156568 005__ 20250516133955.0 000156568 0247_ $$2doi$$a10.1111/jdv.16742 000156568 0248_ $$2sideral$$a118902 000156568 037__ $$aART-2020-118902 000156568 041__ $$aeng 000156568 100__ $$aChernyshov, PV 000156568 245__ $$aQuality of life measurement in occupational skin diseases. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Occupational Skin Disease 000156568 260__ $$c2020 000156568 5060_ $$aAccess copy available to the general public$$fUnrestricted 000156568 5203_ $$aThe European Academy of Dermatology and Venereology (EADV) has started the ''Healthy Skin @ Work'' campaign aimed to raise awareness among the public and EU authorities on the frequency and impact of occupational skin diseases (OSDs). The EADV Task Forces (TFs) on Quality of Life and Patient Oriented Outcomes (QoL/PO) and on OSD present their mutual position statement on QoL assessment in OSDs. The EADV TFs recommend the use of the DLQI as a dermatology-specific instrument and SF-36 as a generic instrument in health-related (HR) QoL studies on OSDs. The OSD-specific questionnaire, LIOD, is not recommended for general use in its present form because of its three months recall period. The EADV TFs discourage the use of non-validated and of non-validated modifications of previously validated HRQoL instruments. The EADV TFs wish to encourage research into: the HRQoL impact of OSDs other than occupational contact dermatitis and hand eczema; comparisons between the effects of different treatments and other interventions on HRQoL in OSDs; and into the HRQoL impairment of patients with OSDs from different countries, and with different provoking factors, to predict if the results of successful therapeutic and educational interventions may be generalized across countries and between occupations. 000156568 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000156568 590__ $$a6.166$$b2020 000156568 591__ $$aDERMATOLOGY$$b7 / 68 = 0.103$$c2020$$dQ1$$eT1 000156568 592__ $$a1.655$$b2020 000156568 593__ $$aInfectious Diseases$$c2020$$dQ1 000156568 593__ $$aDermatology$$c2020$$dQ1 000156568 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000156568 700__ $$aJohn, SM 000156568 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, L$$uUniversidad de Zaragoza 000156568 700__ $$aGoncalo, M 000156568 700__ $$aSvensson, A 000156568 700__ $$aBewley, A 000156568 700__ $$aEvers, AWM 000156568 700__ $$aSzepietowski, JC 000156568 700__ $$0(orcid)0000-0001-5632-0351$$aMarron, SE$$uUniversidad de Zaragoza 000156568 700__ $$aManolache, L 000156568 700__ $$aPustisek, N 000156568 700__ $$aSuru, A 000156568 700__ $$aSalavastru, CM 000156568 700__ $$aTiplica, GS 000156568 700__ $$aSalek, MS 000156568 700__ $$aFinlay, AY 000156568 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac 000156568 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología 000156568 773__ $$g34, 9 (2020), 1924-1931$$pJEADV, J. Eur. Acad. Dermatol. Venereol.$$tJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY$$x0926-9959 000156568 8564_ $$s236289$$uhttps://zaguan.unizar.es/record/156568/files/texto_completo.pdf$$yVersión publicada 000156568 8564_ $$s2205297$$uhttps://zaguan.unizar.es/record/156568/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000156568 909CO $$ooai:zaguan.unizar.es:156568$$particulos$$pdriver 000156568 951__ $$a2025-05-16-12:26:44 000156568 980__ $$aARTICLE